Edwards Lifesciences Corp (NYSE:EW) over-valued by 12%
| Website | https://www.edwards.com |
| Sector | Healthcare |
| Industry | Medical Devices |
| Fiscal Year End | Dec 31, 2020 |
| Market Cap | $59,242,704,896 |
| Beta | 0.89386 |
| Average Volume | $2,752,066 |
| Last Dividend | 0% |
| Price on Feb 12, 2021 | $95.24 |
| Autochartist™ Valuation | $83.95 |
| Conclusion |
12% over-valued |
| Download Report |
